Cyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With Cancer

NCT00949117 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped study not feasible with low accrual. DSMB recommended closure

Conditions

Leukemia
Lymphoma
Malnutrition
Myelodysplastic Syndromes
Unspecified Childhood Solid Tumor, Protocol Specific
Weight Changes

Interventions

DIETARY_SUPPLEMENT: Ensure
DIETARY_SUPPLEMENT: PediaSure
DRUG: cyproheptadine hydrochloride

Sponsor

University of South Florida

Collaborators

[object Object]